about
Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patientsTherapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel DiseaseLactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposesProbiotics and the gastrointestinal tract: where are we in 2005?Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407.Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity.Purified cell wall from the probiotic bacterium Lactobacillus gasseri activates systemic inflammation and, at higher doses, produces lethality in a rat modelSafety assessment of probiotics for human use.Involvement of the mannose receptor and p38 mitogen-activated protein kinase signaling pathway of the microdomain of the integral membrane protein after enteropathogenic Escherichia coli infection.Characterization and pharmacological potential of Lactobacillus sakei 1I1 isolated from fresh water fish Zacco koreanus.Probiotics and their Effects on Metabolic Diseases: An Update.Use of probiotics in aquaculture.Probiotic features of two oral Lactobacillus isolatesBeneficial Properties of Probiotics.Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice.Microbial characterization of probiotics--advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC).Bile-mediated aminoglycoside sensitivity in Lactobacillus species likely results from increased membrane permeability attributable to cholic acidStrain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock.Neuroprotective Effects of Clostridium butyricum against Vascular Dementia in Mice via Metabolic Butyrate.Probiotics for diarrhoeaProbiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress.Acetobacter cibinongensis bacteremia in human.Probiotics in the arabian gulf region.A Novel Prebiotic Blend Product Prevents Irritable Bowel Syndrome in Mice by Improving Gut Microbiota and Modulating Immune Response.Genotoxicity assessment of multispecies probiotics using reverse mutation, mammalian chromosomal aberration, and rodent micronucleus tests.
P2860
Q21195017-9725BEBC-43AC-4727-867E-B2FAC6E8E860Q26771122-B692B717-EDA5-4AAB-A5AB-A22BAF10566BQ26786083-C82AE269-2209-4E5B-8C2F-E045E645C0A1Q33788552-6057ABA8-E2CD-4C9B-889A-7B99EEEDAF61Q33844207-BB901D23-92B5-4F97-8767-A722BDE52365Q34025073-7088C8C6-E672-48A1-B7A7-BA1844A6700DQ34041860-BDAAFCFE-F5A2-47DA-98BC-B4B51BBCB1E5Q34485263-40FEEFA2-F88E-4209-B838-5069F809B8FDQ34503589-A80568D7-8C90-48C1-80F3-347AF7562274Q35867542-434BB9C5-9E5C-4587-A610-27EABF79E018Q35958692-ECD44AE2-4F2E-4C75-91C3-F0D2E0EC4ECCQ36622603-BD9CCA87-4C41-434A-8877-081E93AEA54FQ36900173-81C0167D-1AD9-48EE-A097-A48FA2EA94E1Q37160193-84BC99E6-EF1F-423F-ADAF-9A3D10BF5E8DQ37272397-20F5D0EB-1113-43A5-9E29-DA8B4D258DB5Q37394024-8C774748-4583-48FB-8192-7EFE2A328B2DQ37542178-98565F36-3231-48B2-9E51-55C8759FE63EQ37701873-AC9E48A1-BAD7-419D-B665-4E255E677178Q40419104-4B5D99BA-AEF4-4A84-A7B4-4B8613061B1EQ40927656-56FEE044-28EA-4DAB-BFCE-690116403199Q41128204-392541EC-3BBC-4C4B-B65D-CB7EB0D8AECBQ42078864-73DF6147-1818-4C49-9158-57555C7269D1Q42546884-1BB0AEEE-5A4E-4A8E-AD7E-5D9A71B446E3Q43167799-9E9E5A76-B7A5-419B-914E-CBD8AFC36BE5Q47160578-5251350A-9773-4268-B4C3-48463A3F77D9Q51751130-B84BF5D3-8F40-4CC1-BF8E-59FFE8170CD5
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Probiotics and safety.
@ast
Probiotics and safety.
@en
Probiotics and safety.
@nl
type
label
Probiotics and safety.
@ast
Probiotics and safety.
@en
Probiotics and safety.
@nl
prefLabel
Probiotics and safety.
@ast
Probiotics and safety.
@en
Probiotics and safety.
@nl
P356
P1476
Probiotics and safety.
@en
P2093
Ishibashi N
Yamazaki S
P304
P356
10.1093/AJCN/73.2.465S
P407
P433
P577
2001-02-01T00:00:00Z